Nanoparticle Co-Delivery of siRNA and Paclitaxel for Cancer Therapy

A research dataset from the University of Mohaghegh Ardabili examines a novel multi-targeted drug delivery system. It likely contains experimental results on the cytotoxicity and cellular uptake of multifunctional nanoparticles co-loaded with siRNA and paclitaxel. The study focuses on MCF-7 cancer cells and evaluates carriers functionalized with folic acid and glucose.

Use Cases

• Compare cytotoxicity of different nanoparticle formulations based on the MTT assay results described.
• Analyze siRNA internalization efficiency based on fluorescence microscopy data mentioned.
• Evaluate the effect of multi-targeting ligands (folic acid and glucose) on cancer cell viability as described in the study.

Strengths

• Dataset is derived from a described experimental protocol involving MTT assays and fluorescence microscopy.
• Focuses on a specific, clinically relevant challenge of drug resistance in cancer therapy.

Limitations

• Row count and specific column names are unknown, limiting suitability assessment.
• Column-level documentation is absent; field semantics must be inferred from the description.
• Last update date is unknown; freshness unverified.

Provenance

Source

University of Mohaghegh Ardabili

Collection Method

Likely contains experimental results from laboratory synthesis and in vitro testing.